Evidence map›Paper›PMID 40022689›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2025

High APEX1 Expression Facilitates Osteosarcoma Cell Proliferation.

Yan Yu Lu, Wen Lu, Jie Zheng, Ju Shu Luo

Abstract read
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Translational cancer research · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yan Yu LuDivision of Spinal Surgery, The First People's Hospital of Yulin (The Sixth Affiliated Hospital of Guangxi Medical University), No. 495 Mid-way of education, Yulin, 537000, Guangxi, China.
Wen LuDivision of Spinal Surgery, The First People's Hospital of Yulin (The Sixth Affiliated Hospital of Guangxi Medical University), No. 495 Mid-way of education, Yulin, 537000, Guangxi, China.
Jie ZhengDivision of Spinal Surgery, The First People's Hospital of Yulin (The Sixth Affiliated Hospital of Guangxi Medical University), No. 495 Mid-way of education, Yulin, 537000, Guangxi, China.
Ju Shu LuoDivision of Spinal Surgery, The First People's Hospital of Yulin (The Sixth Affiliated Hospital of Guangxi Medical University), No. 495 Mid-way of education, Yulin, 537000, Guangxi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteosarcoma (OS) is a serious malignancy affecting children and young adults; however, there is limited improvement in the survival of patients with OS over the past four decades. Molecular targeted therapy is a promising treatment strategy for OS. Apurinic/apyrimidinic exonuclease 1 (APEX1)-a key factor for DNA damage repair-is associated with OS proliferation, but the underlying molecular mechanism remains unclear. APEX1 expression in OS tissues and paired paracancerous tissues and in human osteoblast cell line hFOB1.19 and OS cell lines was determined using real-time quantitative PCR (RT-qPCR). APEX1-shRNA and NC-shRNA lentiviral vectors were constructed and transfected into MG-63 cells. The effects of APEX1 knockdown on MG-63 cell proliferation and apoptosis were assessed using MTT, xenograft tumor growth, and terminal deoxynucleotidyl transferase dUTP nick end labeling assays. Expression changes of apoptosis- and angiogenesis-related genes due to APEX1 knockdown were detected using RT-qPCR and immunohistochemistry. To preliminarily determine the mechanism by which APEX1 affects OS cell proliferation, transcription factors were predicted using three databases, and construction of protein-protein interaction network, gene ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analyses were performed. APEX1 expression was higher in OS tissues than in paracancerous tissues. APEX1 expression was also higher in OS cell lines than in hFOB1.19 cells, with the highest APEX1 expression observed in MG-63 cells. APEX1 knockdown mediated by APEX1-shRNA lentivirus markedly suppressed MG-63 cell proliferation both in vitro and in vivo and induced their apoptosis. APEX1 knockdown downregulated CD31 expression but had no effect on the expression of P53 and Caspase3. Bioinformatics analyses suggested that USF1 or SP1 regulates APEX1 transcription and its recruitment in DNA damage response pathways, affecting OS cell proliferation. Thus, high APEX1 expression in OS facilitates cell proliferation likely via CD31, and USF1 or SP1 may regulate APEX1 transcription and its recruitment in DNA damage response pathways.

Indexed as

Bone NeoplasmsCell ProliferationDNA-(Apurinic or Apyrimidinic Site) LyaseOsteosarcomaAnimalsApoptosisBiomarkers, TumorFemaleGene Expression Regulation, NeoplasticHumansMaleMiceMice, Inbred BALB CMice, NudeTumor Cells, CulturedXenograft Model Antitumor AssaysAPEX1 protein, humanBiomarkers, TumorDNA-(Apurinic or Apyrimidinic Site) LyaseApurinic/apyrimidinic exonuclease 1DNA damage responseosteosarcomaPlatelet endothelial cell adhesion molecule-1Tumor proliferation

Identifiers

PMID40022689
PMCPMC12118012

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.